The Daily SignalOctober 8, 2026

FDA Approves Chemotherapy-Free Maintenance in Frontline HER2-Positive Breast Cancer.

PLUS: How Novartis took oral BTK inhibition into physical friction hives.

By Dr. Dereck Mush

MD, MBA

Published October 8, 2026

Archive
ShareLink copied
FDA Approves Chemotherapy-Free Maintenance in Frontline HER2-Positive Breast Cancer.
ShareLink copied

Related reading

Your daily HealthTech Signal

No hype. Just signal.

Get the latest HealthTech news, understand why it matters, and see where the industry is headed.

5-minute read Delivered daily Unsubscribe anytime

Read by teams at companies like:

Mayo Clinic logoMayo ClinicCleveland Clinic logoCleveland ClinicJohns Hopkins logoJohns HopkinsKaiser Permanente logoKaiser PermanenteEpic logoEpicPhilips logoPhilipsMedtronic logoMedtronicGE HealthCare logoGE HealthCare